EWING, N.J.--(BUSINESS WIRE)--Redpoint Bio Corporation (OTCBB: RPBC), a company developing compounds to improve the taste of pharmaceutical, food and beverage products, today announced the appointment of Scott A. Siegel, Ph.D., to the position of Vice President of Corporate Development. In his new role, Dr. Siegel will be responsible for the Company’s business development strategy and execution and will report directly to Dr. Ray Salemme, Chief Executive Officer.
